Technology
Health
Medical

Atossa Therapeutics

$2.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+5.17%) Today
+$0.11 (+4.51%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ATOS and other stocks, options, ETFs, and crypto commission-free!

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. Read More The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. The ArgusCYTE Breast Health Test offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

CEO
Steven C. Quay
Employees
6
Headquarters
Seattle, Washington
Founded
2008
Market Cap
25.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
427.98K
High Today
$2.55
Low Today
$2.32
Open Price
$2.32
Volume
395.77K
52 Week High
$5.08
52 Week Low
$0.755

Collections

Technology
Health
Medical
Cancer Prevention
Pharmaceutical
Therapy
US
North America

ATOS News

BenzingaSep 17

Why Atossa Therapeutics Stock Is Trading Higher Today

Atossa Therapeutics (NASDAQ: ATOS) shares are trading higher on Thursday after Ascendiant Capital initiated coverage on the stock with a Buy rating and a price

ATOS Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 12

You May Also Like

AUTO
MFM
RDS.B
BAESY
MPW
SMCI
CTAA
DOV
GWRS
IBND
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.
Buy ATOS
Market Price
$2.55
Commissions
$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ATOS stock and options commission-free.
LearnBlogCareersHelpLog InSign Up